- Home
- KRYS vs QLYS Comparison
KRYS vs QLYS Comparison
Compare KRYS & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- QLYS
- Stock Information
- Founded
- KRYS 2015
- QLYS 1999
- Country
- KRYS United States
- QLYS United States
- Employees
- KRYS N/A
- QLYS N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- QLYS Computer Software: Prepackaged Software
- Sector
- KRYS Health Care
- QLYS Technology
- Exchange
- KRYS Nasdaq
- QLYS Nasdaq
- Market Cap
- KRYS 4.3B
- QLYS 4.7B
- IPO Year
- KRYS 2017
- QLYS 2012
- Fundamental
- Price
- KRYS $150.49
- QLYS $134.54
- Analyst Decision
- KRYS Strong Buy
- QLYS Hold
- Analyst Count
- KRYS 10
- QLYS 15
- Target Price
- KRYS $204.90
- QLYS $141.00
- AVG Volume (30 Days)
- KRYS 422.6K
- QLYS 344.7K
- Earning Date
- KRYS 08-04-2025
- QLYS 08-05-2025
- Dividend Yield
- KRYS N/A
- QLYS N/A
- EPS Growth
- KRYS 36.22
- QLYS 10.84
- EPS
- KRYS 4.91
- QLYS 5.02
- Revenue
- KRYS $359,205,000.00
- QLYS $637,019,000.00
- Revenue This Year
- KRYS $34.33
- QLYS $9.67
- Revenue Next Year
- KRYS $47.84
- QLYS $6.63
- P/E Ratio
- KRYS $30.77
- QLYS $26.80
- Revenue Growth
- KRYS 116.08
- QLYS 9.63
- 52 Week Low
- KRYS $122.80
- QLYS $112.61
- 52 Week High
- KRYS $207.84
- QLYS $170.00
- Technical
- Relative Strength Index (RSI)
- KRYS 56.41
- QLYS 52.21
- Support Level
- KRYS $142.51
- QLYS $129.88
- Resistance Level
- KRYS $147.58
- QLYS $133.69
- Average True Range (ATR)
- KRYS 4.78
- QLYS 3.62
- MACD
- KRYS 0.39
- QLYS 0.61
- Stochastic Oscillator
- KRYS 92.81
- QLYS 86.00
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.